Each month we provide an overview of University of Missouri School of Medicine faculty-authored articles in medicine and related fields as well as a featured article with the highest journal impact factor.
This month’s featured article, “Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial”, was co-authored by Dr. Richard Barohn of the Department of Neurology and Executive VC for Health Affairs & the Hugh E. & Sarah D. Stephenson Dean, School of Medicine. The article was published in The Lancet Neurology (impact factor of 48.0 in 2022).
Note that Dr. James Stevermer also had a publication in JAMA as a member of the USPSTF:
See the list of publications in medicine and related fields we retrieved for this month: https://library.muhealth.org/facpubmonthlyresult/?Month=September&Year=2023